| BSE: 524669 | Sector: Health care |
| NSE: HESTERBIO | ISIN Code: INE782E01017 |
| BSE 00:00 | 17 Jan | 1602.00 |
16.85 (1.06%) |
OPEN
1617.25 |
HIGH
1635.00 |
LOW
1600.00 |
| NSE 00:00 | 17 Jan | 1603.25 |
9.65 (0.61%) |
OPEN
1608.20 |
HIGH
1634.00 |
LOW
1595.25 |
| OPEN | 1617.25 |
| PREVIOUS CLOSE | 1585.15 |
| VOLUME | 392 |
| 52-Week high | 2044.40 |
| 52-Week low | 1043.25 |
| P/E | 31.89 |
| Mkt Cap.(Rs cr) | 1,363 |
| Buy Price | 1580.75 |
| Buy Qty | 1.00 |
| Sell Price | 1641.00 |
| Sell Qty | 1.00 |
11.04 pm | 17 Jan 2020 | Business Standard
The company said it was a strategic investment for PEL and it decided to sell as it saw good value for its shareholders. The sale value is roughly fiv...
3.49 pm | 17 Jan 2020 | Business Standard
In the first 11 trading days of the current calendar year, Dr Reddy's has outperformed the market by surging 6 per cent on expectations of earnings im...
2.40 pm | 17 Jan 2020 | Press Trust of India
This divestment is expected to be completed by end of February 2020, Piramal Enterprises (PEL)said in a statement
2.36 pm | 17 Jan 2020 | Business Standard
The company signed a definitive agreement for the sale of DRG to Clarivate Analytics plc, a global leader in providing trusted insights and analytics,...
1.44 pm | 17 Jan 2020 | Business Standard
The board approved the buy-back of equity shares by the Company from open market through stock exchange mechanism for amount not exceeding Rs 72 crore...
1.43 pm | 17 Jan 2020 | Business Standard
While multinational companies have launched new antibiotics in India, there have been no new launches in the past 15 years in this category
8.18 am | 17 Jan 2020 | Business Standard
Biocon has maintained a strong base near 280 levels which is a good support level and currently has indicated a positive bullish candle pattern to imp...
8.32 pm | 16 Jan 2020 | Business Standard
Since, 2002, Metropolis has used its brand strength to establish large networks through acquisitions in Chennai, Rajkot, Surat, Bangalore, Pune as wel...
9.06 am | 16 Jan 2020 | Business Standard
Shares of Avanti Feeds jumped over 80% in the last 3 months while those of Dr Lal PathLabs climbed around 38% in 6 months. Shares of Deepak Nitrite & ...
8.16 am | 16 Jan 2020 | Business Standard
Technical Calls by Gaurav Garg, Head of Research at CapitalVia Global Research Limited- Investment Advisor
12.45 am | 16 Jan 2020 | Press Trust of India
Drug firm Alembic Pharmaceuticals on Wednesday said it has received final nod from the US health regulator for Tizanidine hydrochloride capsules, used...
11.13 pm | 15 Jan 2020 | Bloomberg
Albert Bourla, CEO of Pfizer, discussed the time frame for the IPO at the JPMorgan Healthcare Conference in San Francisco on Tuesday
8.16 am | 14 Jan 2020 | Business Standard
In Nifty, traders are advised not to be adventurous by taking positions against the major direction
11.26 pm | 13 Jan 2020 | Business Standard
Further rerating of stock will hinge on USFDA resolution
12.36 pm | 13 Jan 2020 | Business Standard
The company, however, said it does not believe that this inspection classification will have an impact on disruption of supplies or the existing reven...
10.51 am | 10 Jan 2020 | Business Standard
Lupin, Sun Pharmaceutical, Cadila Healthcare, Aarti Drugs and Aurobindo Pharma were up in the range of 2 per cent to 3 per cent.
10.51 am | 10 Jan 2020 | Business Standard
Lupin, Sun Pharmaceutical, Cadila Healthcare, Aarti Drugs and Aurobindo Pharma were up in the range of 2 per cent to 3 per cent.
10.51 am | 10 Jan 2020 | Business Standard
Lupin, Sun Pharmaceutical, Cadila Healthcare, Aarti Drugs and Aurobindo Pharma were up in the range of 2 per cent to 3 per cent.
10.51 am | 10 Jan 2020 | Business Standard
Lupin, Sun Pharmaceutical, Cadila Healthcare, Aarti Drugs and Aurobindo Pharma were up in the range of 2 per cent to 3 per cent.
10.51 am | 10 Jan 2020 | Business Standard
Lupin, Sun Pharmaceutical, Cadila Healthcare, Aarti Drugs and Aurobindo Pharma were up in the range of 2 per cent to 3 per cent.
